About Aitia
Aitia is a biotechnology company focused on transforming drug discovery and development through advanced artificial intelligence and computational biology approaches. The company develops AI-powered platforms that analyze complex biological systems to identify novel therapeutic targets and optimize drug development pathways. By integrating multi-omics data, systems biology, and machine learning, Aitia aims to accelerate the discovery of effective treatments for complex diseases. The company's technology platform enables researchers and pharmaceutical partners to better understand disease mechanisms, predict drug responses, and reduce the time and cost associated with bringing new therapies to market. Aitia serves pharmaceutical companies, biotechnology firms, and research institutions seeking to enhance their drug discovery capabilities through computational approaches.
Who It Serves
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
A2A Pharmaceuticals
AI-driven pharmaceutical company focused on discovering and developing novel drug candidates using computational biology and machine learning.
AbCellera
AbCellera uses AI and machine learning to discover and develop antibody-based therapeutics and vaccines.
Absci
Absci uses AI-powered computational biology and machine learning to accelerate drug discovery and optimize therapeutic proteins and antibodies.
Adaptyv Bio
11-50 employees
Adaptyv Bio operates the world's fastest protein validation lab, providing automated experimental testing services for AI-designed proteins. The company enables protein engineers to validate binding, expression, and thermostability of novel protein designs through a fully automated platform with 3-week turnaround times.
Anagenex
Anagenex is a biotechnology company focused on drug discovery and development. The company appears to operate in the pharmaceutical research space, though specific details about their technology platform, therapeutic areas, and target markets are not available from the provided content.
Aqemia
Aqemia is a drug discovery company advancing next-generation medicines using generative AI and deep physics. The company combines AI-augmented discovery with computational chemistry to develop novel therapeutics at scale.
Arctoris
51-200 employees
Arctoris is a Partnership Research Organisation (PRO) providing automated wet lab biology R&D and data generation services for biotech, techbio, and pharma companies through its Ulysses® robotic platform.
Aria Pharmaceuticals
Aria Pharmaceuticals appears to be a pharmaceutical company focused on drug discovery and development. Based on the limited information available, the company operates in the pharmaceutical sector.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.